Dhiti Omics

Dhiti Omics is a precision molecular diagnostics service provider offering tests using state-of-the-art genomics technologies. Our objective is to provide deeper insight into diagnosis for rare and difficult diseases through clinical genomics collaborating with subject matter experts. We are specialized in Rare Disease, Inherited Disorders, Oncology, Pharmacogenomics, and Infectious Disease diagnosis. Our genomic-based clinical diagnostics and research, harness tools such as Next Generation Sequencing, Microarrays, Sanger Sequencing, PCR and qRT-PCR to solve the toughest diagnostic cases. We assist you in the early detection of disease, risk stratification, prognostication, and prediction of response to therapy

Cardiomyopathy risk screening,autism spectrum disorder screening,tumor mutation profiling,inherited diseases mutations,maturity onset diabetes screening,high-resolution hla typing,neuro-muscular disorders,disease-causing mutations in exome,rare disease diagnosis,inherited disorder,infectious disease panel,pharmacogenomics,oncology,oncogenomics,whole genome sequencing,whole exome sequencing,and single gene tests

Dhiti omics operates in the Biotechnology research industry.

Dhiti omics's revenue is 11m - 100m

Dhiti omics has 11 - 50 employees.